EPA World Congress 2022

March 22-24, 2022, Amsterdam
Events
Category:
Published on:
February 2, 2022

We are thrilled to sponsor and attend World EPA Congress 2022, Europe’s Leading Pricing, Market Access and Evidence Congress for the Biopharma Industry.

The event will feature 250 speakers, multiple streams, and over 1000 attendees from pharma, biotech, and Payers/HTA’s. The 2022 edition will now take place over three days with expanded content on RWE, HTA, Medical Devices, Affordability, Digital Health, Analytics and Emerging Markets. The event’s core topic areas will include Market Access and Pricing, Rare Diseases, HTA/Payer, and Evidence and will cover the latest trends in reimbursement, payment models, affordability, HEOR, and many other developments within the industry.

As part of the event, our very own Andrea Mantovani, Vice President, Global Market Access will also host a roundtable “Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective”.

Our attendees:

 

Related news

Multimedia June 21, 2022
Increasing Access to Genomic Testing in Europe
Listen to the episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics”.
Genomic Testing Market Access MedTech
Multimedia May 10, 2022
VacciTalks: Behind the Scenes: Challenging Race of Vaccine Development
Join the 2nd episode of VacciTalks where together with vaccine expert Roberto Camerini we will peek behind the scenes of vaccine development and get an insider look at the difficulties,(...)
Market Access
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
Multimedia April 28, 2022
Alira Health’s Transformation Talks: Real-World Data to Support HTAs in Europe
Learn more about RWD as a support in HTAs and its direct impact on HTAs budgets, results, and even patient outcomes by listening to this episode of Transformation Talks.
Clinical Market Access RWE
Publications April 20, 2022
White Paper: Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective
In this white paper, we will explore wide range of new therapies we term “Next Generation Therapies” and challenges related to them.
Market Access
Publications March 31, 2022
Real-World Evidence: Five Facts You Need to Know
Learn more about RWD and its future challenges for Europe, we asked Romain Finas, Vice President of Real-World Evidence (RWE) at Alira Health, to share five facts that you need to know about it.
Market Access RWE
Publications March 25, 2022
Early Access Programs: Keys to Success
Discover Alira Health’s top five recommendations to building a successful Early Access Programs (EAP). 
Market Access
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.